Company Filing History:
Years Active: 2011-2015
Title: Meredith W. Miller: Innovator in Integrin Inhibitors
Introduction
Meredith W. Miller is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of integrin inhibitors. With a total of 2 patents, her work focuses on novel compounds that have therapeutic applications.
Latest Patents
Miller's latest patents include innovative compounds that inhibit the integrin α2β1/GPIa-IIa receptor. The first patent discloses inhibitors based on a prolyl diaminopropionic acid scaffold. These compounds are not only novel but also include pharmaceutical compositions and methods for their therapeutic use. The second patent features inhibitors of integrin α2β1 with a modified urea moiety, which also presents pharmaceutical compositions and therapeutic methods. Both patents highlight the compounds' utility as inhibitors of integrin α2β1/GPIa-IIa-mediated activity.
Career Highlights
Miller is affiliated with the University of Pennsylvania, where she continues her research and development in the field of integrin inhibitors. Her work has garnered attention for its potential impact on therapeutic applications in various medical conditions.
Collaborations
Some of her notable coworkers include Sandeep Basra and Joel S. Bennett, who contribute to her research endeavors and collaborative projects.
Conclusion
Meredith W. Miller is a dedicated inventor whose work in integrin inhibitors showcases her commitment to advancing pharmaceutical sciences. Her innovative patents reflect her expertise and the potential for significant therapeutic advancements.